Johnson Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

U.S. pharmaceutical company Johnson & Johnson announced Wednesday that clinical trials it has conducted show a second shot of the company’s COVID-19 vaccine produced an antibody response nine times higher than the original single dose. In a news release, the company said it conducted two Phase 1/2a studies in individuals previously vaccinated with its single-shot…

Share this article Share this article NEW BRUNSWICK, N.J., July 1, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants. In addition, the data showed that the durability of the immune response lasted through at least eight months, the length of time evaluated to date. The two preprint study summaries have been submitted today to bioRxiv. "Today's newly announced studies rein...

As of March 8, four COVID-19 vaccines have been approved for emergency use in Canada. Two of them, the mRNA vaccines from Pfizer/BioNTech and Moderna vaccines, were approved for use in Canada in December 2020. The Oxford/AstraZeneca vaccine was approved on Feb. 26, followed by the Johnson & Johnson vaccine on March 5. A fifth vaccine was submitted on Jan. 29 by Novavax for approval in Canada. If approved, the vaccine would be produced in Canada. How effective these vaccines may be in ending the COVID-19 pandemic has been equated to their “efficacy rates.” It’s important to know what t...

of LEXINGTON, Ky. (March 4, 2021) — March marks one year since the COVID-19 global pandemic disrupted and altered everyone’s life. On March 6, it will be a year since Kentucky confirmed the first case of COVID-19 – a patient admitted to UK Chandler Hospital. A few days later, on March 11, the University of Kentucky announced it would transition its campus of more than 30,000 students to online instruction – initially just for two weeks following spring break -- but eventually from March 23 through the end of the Spring 2020 semester. Additionally, on March 20, UK President Eli Capil...

News24/Alex Mitchley The Dr George Mukhari Academic Hospital is the latest site in Gauteng to administer the Covid-19 jab. Gauteng wants to vaccinate 8 520 healthcare workers this week.  The J&J Phase 3b Implementation Study has, so far, seen  17 994 healthcare workers receiving the jab. As the Dr George Mukhari Academic Hospital in Tshwane became the latest site in Gauteng to administer the Covid-19 jab, the province is looking to vaccinate 8 520 more healthcare workers this week. South Africa has begun vaccinating healthcare workers against the novel coronavirus as part of the Johnson & ...